RxDoctor Payments Data

Paul Bulow, DO

Internal Medicine · Tinley Park, ILNPI 1588700926

Payments from drug & device makers

$8,247in general payments, 2019–2025

Across 458 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$858
  • Novo Nordisk$796
  • Lilly USA, LLC$704
  • Boehringer Ingelheim$670
  • Pfizer$625
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$8,222100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,247 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$265,344
Medicare patients
483
Services billed
24,190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban100$105,367
JardianceEmpagliflozin40$65,215
OzempicSemaglutide50$63,487
XifaxanRifaximin14$44,470
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$36,709
JanuviaSitagliptin Phosphate49$32,600
RybelsusSemaglutide19$28,981
FarxigaDapagliflozin Propanediol24$25,909
MounjaroTirzepatide24$24,374
XareltoRivaroxaban21$21,725
Breo ElliptaFluticasone/Vilanterol30$13,753
MyrbetriqMirabegron17$12,312
OxycontinOxycodone Hcl11$11,057
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,875
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen277$6,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$625$105,367100 claims
Novo NordiskOzempic, Rybelsus$796$92,46769 claims
Boehringer IngelheimJardiance$670$65,21540 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$98$54,82590 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$402$44,47014 claims
AstraZenecaFarxiga, Breztri Aerosphere$858$34,78438 claims
MerckJanuvia$79$32,60049 claims
Lilly USA, LLCMounjaro$704$24,37424 claims
Johnson & JohnsonXarelto$162$21,72521 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$46$4,569380 claims
AbbVieSynthroid$1,269$2,39525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Tinley Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →